Obestatin is encoded within the same precursor as ghrelin, preproghrelin, and was proposed as a counterpart to it in the regulation of food intake. The supplied human sequence is a 23-residue amidated peptide, and the shared precursor is what makes it interesting: a single gene product yielding peptides reported to have opposing effects raises questions about processing and relative abundance that a single peptide cannot answer. The field around obestatin has been contested, with reports on its receptor and on the reproducibility of its effects on feeding differing between laboratories. That history is worth knowing when planning experiments rather than discovering afterwards: assay conditions, peptide integrity and the presence or absence of C-terminal amidation have all featured in the discussion, and amidation in particular is generally regarded as required for activity, so a non-amidated preparation is not equivalent. This is the human sequence. Comparing it against the rodent form (LT1936) shows a substitution within the C-terminal half, so the two are not interchangeable in immunoassays raised against one species, and cross-reactivity should be established rather than assumed when quantifying the peptide in samples. | 